Key Market Indicators
Greek insulin imports are projected to climb to approximately $57.5 million by 2028, up from $56.4 million in 2023, marking a modest annual growth rate of 0.2%. This comes after a long-term decline in demand, which has decreased by an average of 2.1% per year since 1993. On the export front, Greece is expected to see more robust growth. Insulin exports are forecasted to reach about $7.4 million by 2028, up from $5.8 million in 2023, translating to an annual growth rate of 3.6%. This continues a positive trend in Greek insulin supply, which has increased by an average of 14.4% per year since 1993. In the global rankings for 2023, Greece was positioned 19th in insulin exports, with Romania surpassing it at the same export value of $5.8 million. Leading the rankings were France, Italy, and China, occupying the second, third, and fourth spots, respectively.
